High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia
Hou Y, Feng Q, Xu M, et al. High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia. Blood. 2016;127(12):1587-1597.
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 2010;116(25):5738-5747.
Circulating dendritic cells subsets and CD41Foxp31 regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome
Ling Y, Cao X, Yu Z, Ruan C. Circulating dendritic cells subsets and CD41Foxp31 regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol. 2007;79(4): 310-316.
Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide
Liao J, Wang X, Bi Y, et al. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide. J Leukoc Biol. 2014; 96(5):675-684.
Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects
Kassel O, Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol. 2007;275(1-2): 13-29.
A murine model of severe immune thrombocytopenia is induced by antibody- and CD81 T cell-mediated responses that are differentially sensitive to therapy
Chow L, Aslam R, Speck ER, et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD81 T cell-mediated responses that are differentially sensitive to therapy. Blood. 2010;115(6): 1247-1253.